WinstonWınston
Back

This stock no longer trades (delisted September 6, 2024)

Delisted / no longer publicly traded (per market data provider) Everything below is based on the last available data — treat it as historical, not a live read.

Stock

Brookfield Reinsurance

BNRE
55
Insurance - Reinsurance · Financial Services
Price
$47.12
-0.38 (-0.80%)
Market Cap
$6.87B
Exchange
New York Stock Exchange
Winston Score
55
Historical score — this stock no longer trades, so the score is frozen at the last available data.
Data as of Oct 18, 2026 · filings through Jun 30, 2024

§How the score breaks down

Quality
Good
15/30
Growth
Good
10/20
Cash Flow
Exceptional
10/10
Stability
Mixed
3/10
Valuation
Good
6/10
Ownership
Good
10/15
Dividends
Weak
1/5

55 of 100 counted points = Winston Score 55.

Share count rising — dilution

+321.9% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 27.8M (2019) → 117.4M (2023)

§Winston Score History

The full picture

Brookfield Reinsurance is a reinsurance company that takes on risk from other insurance companies. When an insurance company wants to reduce its exposure to large claims, it pays Brookfield Reinsurance to absorb some of that risk. The company is part of the broader Brookfield Asset Management family and focuses on life and annuity reinsurance.

Brookfield Reinsurance makes money by collecting premiums from insurance partners and investing those funds to earn returns over time. It operates primarily in North America and the Caribbean, with access to Brookfield's large-scale investment platform as a key competitive advantage. The company's strategy centers on acquiring or reinsuring blocks of insurance policies, then using Brookfield's investment expertise to generate higher returns on the assets backing those policies. Growth depends on its ability to source new reinsurance deals and deliver strong investment performance, while rising interest rates or poor investment results represent meaningful risks.

Politician Trades

2 trades / 12mo

2 Congressional buys and 0 sells on BNRE in the last 12 months.

Unlock the full Smart Money Map — every trade plotted on the price chart with politicians, amounts and returns since each trade. Founder's Deal is $57/mo locked for life.

Unlock politician trades

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+40.3% YoY

YoY Growth Rate

Strong revenue growth

EPS Growth

-74.2% YoY

YoY Growth Rate

Earnings declining

R&D Spend

$0/ year

0.0% of revenue

Below sector average (7%)

Research and development spending

Insider Activity

81.7%ownership

Insiders own a meaningful stake in the company

Cash Position

Cash flow positive

$87.4B cash & investments

Quarterly Free Cash Flow

→ Burn rate stable

Company generates more cash than it spends — no dilution risk from fundraising

Strong grower

Brookfield Reinsurance is growing revenue at 40% year-over-year. The Winston Score penalises unprofitable companies, but revenue at this pace tells a different story — this is a company still in "build mode."

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
100.4%
Premium pricing power — 100.4% gross margin
Profit after running costs
Operating Margin
7.6%
Modest — 7.6% operating margin
Return on the money invested
ROCE
3.7%
Weak — 3.7% return on capital

ROIC between 0% and 5%. They earn a few cents back per dollar invested in the business.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
+39.0%
Fast-growing sales (+39.0% YoY)
Profit growth
EPS YoY
-23.9%
Earnings shrinking (-23.9% YoY)

Earnings per share down more than 10%. Either a bad year, or a real decline.

How steady the profit is
EPS Consistency
5/8 quarters
Mixed — about half the quarters showed growth

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
196%
Turns 196% of profit into real cash
Spare cash per sale
FCF Margin
21.6%
Converts sales into free cash efficiently (21.6%)

Free cash flow margin above 20%. Out of every $100 in sales, more than $20 is real cash they keep.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.72
Moderate — manageable debt (0.72)
Covers its interest
Interest Cover
0.56x
Dangerous — barely covers interest (0.6x)

Interest coverage below 1. Their profits don't cover the interest bill.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
4.8x
Attractive valuation — P/E 4.8

P/E under 10. The price tag is small relative to last year's profit.

Cheaper or dearer next year
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend
Dividend Yield
0.68%
Small dividend — 0.68% yield

Modest yield. The bulk of any return needs to come from price appreciation.

Dividend record
Dividend Growth
-11.4%
Dividend cut (-11.4% YoY) — warning sign

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial